Lung Kee Group Holdings Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Lung Kee (Bermuda) Holdings.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Machinery	16.8%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Lung Kee (Bermuda) Holdings Limited's (HKG:255) Business Is Trailing The Industry But Its Shares Aren't

Jan 09

Lung Kee (Bermuda) Holdings (HKG:255) Is Paying Out Less In Dividends Than Last Year

Aug 28

Lung Kee (Bermuda) Holdings (HKG:255) Will Pay A Smaller Dividend Than Last Year

May 30

Lung Kee (Bermuda) Holdings' (HKG:255) Dividend Will Be Reduced To HK$0.06

Apr 04

Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15

Aug 29

Something To Consider Before Buying Lung Kee (Bermuda) Holdings Limited (HKG:255) For The 9.1% Dividend

Mar 29

What These Trends Mean At Lung Kee (Bermuda) Holdings (HKG:255)

Mar 09

Estimating The Intrinsic Value Of Lung Kee (Bermuda) Holdings Limited (HKG:255)

Feb 16

Here's What Lung Kee (Bermuda) Holdings Limited's (HKG:255) Shareholder Ownership Structure Looks Like

Jan 29

If You Had Bought Lung Kee (Bermuda) Holdings (HKG:255) Shares Three Years Ago You'd Have A Total Return Of Negative 12%

Jan 10

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Dec 20

Are Dividend Investors Making A Mistake With Lung Kee (Bermuda) Holdings Limited (HKG:255)?

Dec 01

Here's What's Concerning About Lung Kee (Bermuda) Holdings (HKG:255)

Nov 18

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Lung Kee Group Holdings no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

SEHK:255 - Estimaciones futuras de los analistas y datos financieros pasados (HKD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	1,454	-72	-36	77	N/A
9/30/2023	1,430	-65	-60	66	N/A
6/30/2023	1,406	-57	-84	55	N/A
3/31/2023	1,506	-20	-95	66	N/A
12/31/2022	1,605	16	-105	77	N/A
9/30/2022	1,800	88	-114	90	N/A
6/30/2022	1,994	161	-122	103	N/A
3/31/2022	2,135	194	15	228	N/A
12/31/2021	2,276	228	152	354	N/A
9/30/2021	2,287	225	223	405	N/A
6/30/2021	2,298	222	294	455	N/A
3/31/2021	2,182	202	268	405	N/A
12/31/2020	2,065	181	242	355	N/A
9/30/2020	2,089	164	237	331	N/A
6/30/2020	2,112	146	231	307	N/A
3/31/2020	2,195	148	241	320	N/A
12/31/2019	2,278	149	250	332	N/A
9/30/2019	2,307	133	279	362	N/A
6/30/2019	2,335	117	308	391	N/A
3/31/2019	2,458	144	272	357	N/A
12/31/2018	2,580	171	237	323	N/A
9/30/2018	2,628	211	190	284	N/A
6/30/2018	2,675	251	144	245	N/A
3/31/2018	2,593	265	149	238	N/A
12/31/2017	2,510	278	155	231	N/A
9/30/2017	2,432	273	N/A	283	N/A
6/30/2017	2,354	267	N/A	336	N/A
3/31/2017	2,284	230	N/A	410	N/A
12/31/2016	2,213	192	N/A	485	N/A
9/30/2016	2,187	164	N/A	491	N/A
6/30/2016	2,160	136	N/A	498	N/A
3/31/2016	2,220	131	N/A	435	N/A
12/31/2015	2,279	126	N/A	373	N/A
9/30/2015	2,358	132	N/A	309	N/A
6/30/2015	2,436	139	N/A	245	N/A
3/31/2015	2,420	139	N/A	201	N/A
12/31/2014	2,403	138	N/A	158	N/A
9/30/2014	2,352	138	N/A	173	N/A
6/30/2014	2,300	138	N/A	188	N/A
3/31/2014	2,261	142	N/A	219	N/A
12/31/2013	2,221	145	N/A	249	N/A
9/30/2013	2,245	170	N/A	329	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 255 es superior a la tasa de ahorro (2.2%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 255 crezcan más rápidamente que el mercado Hong Kong

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 255 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 255 crezcan más rápidamente que el mercado de Hong Kong.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 255 crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 255 se prevé que sea elevada dentro de 3 años.

Lung Kee Group Holdings Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2022

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Recent updates

Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2023

Lung Kee (Bermuda) Holdings Limited, Annual General Meeting, May 27, 2024

Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2023 Results on Mar 22, 2024

Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares

Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares

Lung Kee (Bermuda) Holdings Limited's (HKG:255) Business Is Trailing The Industry But Its Shares Aren't

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Upcoming dividend of HK$0.05 per share at 7.6% yield

Lung Kee (Bermuda) Holdings (HKG:255) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: HK$0.05 loss per share (vs HK$0.065 profit in 1H 2022)

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2023 Results on Aug 25, 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lung Kee (Bermuda) Holdings (HKG:255) Will Pay A Smaller Dividend Than Last Year

Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2022

Upcoming dividend of HK$0.06 per share at 5.9% yield

Lung Kee (Bermuda) Holdings' (HKG:255) Dividend Will Be Reduced To HK$0.06

Full year 2022 earnings released: EPS: HK$0.025 (vs HK$0.36 in FY 2021)

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2022

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Upcoming dividend of HK$0.06 per share

Lung Kee (Bermuda) Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2022, Payable on September 27, 2022

First half 2022 earnings released: EPS: HK$0.065 (vs HK$0.17 in 1H 2021)

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2022 Results on Aug 26, 2022

Investor sentiment deteriorated over the past week

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Lung Kee (Bermuda) Holdings Limited Declares Final Dividend

Upcoming dividend of HK$0.20 per share

Less than half of directors are independent

Lung Kee (Bermuda) Holdings Limited Appoints Ms. He Lamei as Independent Non-Executive Director, Member of Each of the Audit Committee, the Nomination Committee and the Remuneration Committee

Upcoming dividend of HK$0.15 per share

First half 2021 earnings released: EPS HK$0.17 (vs HK$0.11 in 1H 2020)

Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15

Investor sentiment improved over the past week

Lung Kee (Bermuda) Holdings Limited Approves and Declares Final Special Dividend

Upcoming dividend of HK$0.28 per share

Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019)

Something To Consider Before Buying Lung Kee (Bermuda) Holdings Limited (HKG:255) For The 9.1% Dividend

Lung Kee (Bermuda) Holdings Limited Recommends Final Special Dividend for the Year Ended 31 December, 2020, Payable on or About 22 June, 2021

Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019)

Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

What These Trends Mean At Lung Kee (Bermuda) Holdings (HKG:255)

Estimating The Intrinsic Value Of Lung Kee (Bermuda) Holdings Limited (HKG:255)

Here's What Lung Kee (Bermuda) Holdings Limited's (HKG:255) Shareholder Ownership Structure Looks Like

If You Had Bought Lung Kee (Bermuda) Holdings (HKG:255) Shares Three Years Ago You'd Have A Total Return Of Negative 12%

New 90-day high: HK$2.61

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Are Dividend Investors Making A Mistake With Lung Kee (Bermuda) Holdings Limited (HKG:255)?

Here's What's Concerning About Lung Kee (Bermuda) Holdings (HKG:255)

New 90-day high: HK$2.50

New 90-day high: HK$2.32

New 90-day high - HK$2.26

First half earnings released

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2020 Results on Aug 28, 2020

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento